(NEW YORK) -- Here's the latest information on the COVID-19 coronavirus as of 9:15 a.m. ET.
Latest reported numbers globally per Johns Hopkins University
Global diagnosed cases: 7,397,349
Global deaths: 417,109. The United States has the most deaths of any single country, with 112,924.
Number of countries/regions: at least 188
Total patients recovered globally: 3,478,385
Latest reported numbers in the United States per Johns Hopkins University
There are at least 2,464,000 diagnosed cases in 50 states the District of Columbia, Puerto Rico and Guam. This is more than in any other country.
U.S. deaths: at least 112,924. New York State has the greatest number of reported deaths in the U.S., with 30,542.
U.S. total patients recovered: 533,504
U.S. total people tested: 21,467,820
The greatest number of reported COVID-19 cases in the U.S. is in New York, with 380,156 confirmed cases out of a total state population of 19.5 million. That is the most reported cases than in any other single region in the world. Moscow, Russia is next, with 201,221 reported cases out of a total population of at least 12.5 million.
Latest reported deaths per state
Visit https://coronavirus.jhu.edu/map.html for the latest numbers.
For a state-by-state interactive map of current school closures, please visit the Education Week website, where numbers are updated once daily.
There are 98,277 public schools and 34,576 private schools in the U.S., according to the National Center for Education Statistics. Those schools educate almost 50.8 million public school students and 5.8 million private school students.
The latest headlines
COVID-19 cases in the US top two million
The number of reported COVID-19 cases in the U.S. has now exceeded two million. The nation officially crossed that threshold Wednesday night, with 2,464,000 cases, according to data from Johns Hopkins University. The milestone has been passed 44 days after the number of reported coronavirus infections in the U.S. exceeded one million. Just two weeks ago, the U.S. death toll from COVID-19 passed 100,000 – that number has already increased to 112,924 as if Thursday morning. Coronavirus infections are reported to be significantly on the upswing in at least 20 states as lockdowns continue to be lifted and social distancing relaxed, with hospitalizations also rising in at least eight of those states, prompting renewed concern among experts that the long-predicted second wave of COVID-19 infections may be underway.
Unemployment claims rise by 1.5 million
An additional 1.542 million Americans applied for unemployment in the week ending May 30, according to numbers released this morning by the Department of Labor. Those numbers are a decrease of 355,000 from the previous week’s revised level, and continues the trend of fewer people applying for unemployment since the COVID-19 pandemic began affecting the economy. While unemployment claims are trending down, the numbers remain at levels not seen since the Great Depression, with more than 40 million Americans now having applied for unemployment benefits during the pandemic. Additionally, the Bureau of Labor Statistics – the government agency that keeps track of the U.S. unemployment rate -- recently revealed that data collection efforts contributed to their June 5 report that U.S. unemployment decreased to 13.3% from April’s reported 14.8%, when a corrected report puts the unemployment level at an increased 16.3%. Federal Reserve officials on Wednesday said they expect total unemployment to be around 9.3% by year’s end, with the U.S. economy shrinking by some 6%.
Two COVID-19 vaccine trials about to begin
Two pharmaceutical companies have announced they’re moving forward with human trials of a potential vaccine for COVID-19. Regeneron is starting two clinical trials for an antibody drug cocktail called REGN-COV2. One trial will see if the company's antibody cocktail can help prevent COVID-19, while the other will see if it can help treat people who have already been infected. The drug is a similar to convalescent plasma, except instead of harvesting antibodies from the blood of someone who has recovered, Regeneron has created man-made antibodies. Meanwhile, pharmaceutical company Moderna announced Phase 3 trials in the U.S. of their mRNA-1273 vaccine against COVID-19, with plans to vaccinate some 30,000 people in July – half with the vaccine and half with a placebo. If the vaccine works and is approved, Moderna says they’re prepared to deliver between 500 million to one billion doses per year beginning in 2021.
Copyright © 2020, ABC Audio. All rights reserved.